127 related articles for article (PubMed ID: 10048492)
1. Angiotension-(1-7) and antihypertensive mechanisms.
Ferrario CM
J Nephrol; 1998; 11(6):278-83. PubMed ID: 10048492
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system.
Ferrario CM; Iyer SN
Regul Pept; 1998 Nov; 78(1-3):13-8. PubMed ID: 9879742
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects of angiotensin-(1-7).
Chappell MC; Iyer SN; Diz DI; Ferrario CM
Braz J Med Biol Res; 1998 Sep; 31(9):1205-12. PubMed ID: 9876288
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Iyer SN; Ferrario CM; Chappell MC
Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
6. Counterregulatory actions of angiotensin-(1-7).
Ferrario CM; Chappell MC; Tallant EA; Brosnihan KB; Diz DI
Hypertension; 1997 Sep; 30(3 Pt 2):535-41. PubMed ID: 9322978
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the hypotensive effect of bradykinin by angiotensin-(1-7)-related peptides.
Paula RD; Lima CV; Britto RR; Campagnole-Santos MJ; Khosla MC; Santos RA
Peptides; 1999; 20(4):493-500. PubMed ID: 10458520
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats.
Paula RD; Lima CV; Khosla MC; Santos RA
Hypertension; 1995 Dec; 26(6 Pt 2):1154-9. PubMed ID: 7498987
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Gironacci MM; Yujnovsky I; Gorzalczany S; Taira C; Peña C
Regul Pept; 2004 Apr; 118(1-2):45-9. PubMed ID: 14759556
[TBL] [Abstract][Full Text] [Related]
10. New insights into actions of the renin-angiotensin system in the kidney: concentrating on the Ang II receptors and the newly described Ang-(1-7) and its receptor.
Arima S; Ito S
Semin Nephrol; 2001 Nov; 21(6):535-43. PubMed ID: 11709801
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
12. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats.
Kangussu LM; Guimaraes PS; Nadu AP; Melo MB; Santos RA; Campagnole-Santos MJ
Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic cardiovascular effects of angiotensin-(1-7) in spontaneously hypertensive rats.
Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
Regul Pept; 2006 Jul; 135(1-2):39-44. PubMed ID: 16678284
[TBL] [Abstract][Full Text] [Related]
14. Differential actions of angiotensin-(1-7) in the kidney.
Chappell MC; Diz DI; Yunis C; Ferrario CM
Kidney Int Suppl; 1998 Dec; 68():S3-6. PubMed ID: 9839274
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
Trask AJ; Ferrario CM
Cardiovasc Drug Rev; 2007; 25(2):162-74. PubMed ID: 17614938
[TBL] [Abstract][Full Text] [Related]
16. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension.
Bürgelová M; Vanourková Z; Thumová M; Dvorák P; Opocenský M; Kramer HJ; Zelízko M; Malý J; Bader M; Cervenka L
J Hypertens; 2009 Oct; 27(10):1988-2000. PubMed ID: 19593210
[TBL] [Abstract][Full Text] [Related]
17. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats.
Dharmani M; Mustafa MR; Achike FI; Sim MK
Eur J Pharmacol; 2007 Apr; 561(1-3):144-50. PubMed ID: 17320855
[TBL] [Abstract][Full Text] [Related]
19. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic rats.
Lemos VS; Côrtes SF; Silva DM; Campagnole-Santos MJ; Santos RA
Br J Pharmacol; 2002 Apr; 135(7):1743-8. PubMed ID: 11934815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
